Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-07

Clinical Trial Update: Clinical Trial to Evaluate Safety and Efficiency of Mesenchymal Stem Cell in Patients With Hidradenitis Suppurativa [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating the safety and efficacy of mesenchymal stem cells in patients with hidradenitis suppurativa (Phase 1/2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Andalusian Network for Design and Translation of Advanced Therapies | Conditions: Hidradenitis Suppurativa | Phase 1, Phase 2 | Status: UNKNOWN